STENOCARE confirms guidance and reports limited capital requirements ahead of the first TO1-warrant subscription starting on 6 December 2023
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOConfirmation of 2023 guidance: Last week, STENOCARE completed the largest delivery to the Danish domestic market to date. The delivery is approximately 30% larger than the previous record in Denmark and covers the patient demand for one quarter. STENOCARE thus fulfils its commitment to security of supply and maintains its all-time-high forecast for 2023 and guidance for Q4-23. Confirmation of 2024 break-even guidance: STENOCARE has built a comprehensive catalogue of initiatives and assets that together are expected